Cellular uptake and intracellular trafficking of oligonucleotides.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2015-06-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.addr.2015.04.005PMID 25881722PMCID PMC4504789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retromer.

  2017cited by this paper
• Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment

  2016cited by this paper
• Retromer and sorting nexins in endosomal sorting.

  2015cited by this paper
• High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides

  2015cited by this paper
• Molecular structure, function, and dynamics of clathrin-mediated membrane traffic.

  2014cited by this paper
• A Bifurcated Proteoglycan Binding Small Molecule Carrier for siRNA Delivery

  2014cited by this paper
• Identification of the endosomal sorting complex required for transport-I (ESCRT-I) as an important modulator of anti-miR uptake by cancer cells

  2014cited by this paper
• Endosome maturation, transport and functions.

  2014cited by this paper
• Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures

  2014influential reference
• Live imaging of endosome dynamics.

  2014cited by this paper
• TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells

  2014influential reference
• Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA

  2014cited by this paper
• Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates

  2014cited by this paper
• Traffic into silence: endomembranes and post-transcriptional RNA silencing

  2014cited by this paper
• Biogenesis and secretion of exosomes.

  2014cited by this paper
• Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides.

  2014cited by this paper
• Multicellular Tumor Spheroids as a Model for Assessing Delivery of Oligonucleotides in Three Dimensions

  2014cited by this paper
• Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.

  2014cited by this paper
• The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy.

  2014cited by this paper
• Clathrin-independent pathways of endocytosis.

  2014cited by this paper
• Tethering the assembly of SNARE complexes.

  2014cited by this paper
• Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology

  2014cited by this paper
• High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting

  2014cited by this paper
• Advances in targeted delivery of small interfering RNA using simple bioconjugates

  2014cited by this paper
• Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications

  2014cited by this paper
• Tethering complexes in the endocytic pathway: CORVET and HOPS

  2013cited by this paper
• Cargo trafficking between endosomes and the trans-Golgi network

  2013cited by this paper
• Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy

  2013cited by this paper
• The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides

  2013cited by this paper
• Exosomes for targeted siRNA delivery across biological barriers.

  2013cited by this paper
• Regulatory watch: Antisense approval provides boost to the field

  2013cited by this paper
• Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells

  2013cited by this paper
• Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides

  2013cited by this paper
• Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy.

  2013cited by this paper
• Nanoparticle-mediated delivery of oligonucleotides to the blood–brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms

  2013cited by this paper
• Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

  2013cited by this paper
• Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses

  2013cited by this paper
• Rab GTPases and membrane identity: Causal or inconsequential?

  2013cited by this paper
• The journey of the organelle: teamwork and regulation in intracellular transport.

  2013cited by this paper
• Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling

  2013cited by this paper
• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cited by this paper
• Caveolae as plasma membrane sensors, protectors and organizers

  2013cited by this paper
• Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.

  2013cited by this paper
• Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides.

  2013cited by this paper
• First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

  2013cited by this paper
• The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing

  2013cited by this paper
• Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

  2013cited by this paper
• Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis

  2013cited by this paper
• Lipid sorting and multivesicular endosome biogenesis.

  2013cited by this paper
• An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.

  2013cited by this paper
• Retrograde transport of protein toxins through the Golgi apparatus

  2013cited by this paper
• Rab GTPase regulation of membrane identity.

  2013cited by this paper
• A Nobel Prize for membrane traffic: Vesicles find their journey’s end

  2013cited by this paper
• Endocytic pathway rapidly delivers internalized molecules to lysosomes: an analysis of vesicle trafficking, clustering and mass transfer.

  2012cited by this paper
• The chemistry and biology of oligonucleotide conjugates.

  2012cited by this paper
• Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells

  2012cited by this paper
• Determination of cellular uptake and intracellular levels of Cenersen (Aezea(®), EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cells.

  2012cited by this paper
• Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells.

  2012cited by this paper
• Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis

  2012cited by this paper
• At the Crossroads of Chemistry and Cell Biology: Inhibiting Membrane Traffic by Small Molecules

  2012cited by this paper
• Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

  2012cited by this paper
• Dantrolene Enhances Antisense-Mediated Exon Skipping in Human and Mouse Models of Duchenne Muscular Dystrophy

  2012cited by this paper
• Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.

  2012cited by this paper
• Endosome maturation

  2011cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• New links between vesicle coats and Rab-mediated vesicle targeting.

  2011cited by this paper
• Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes

  2011cited by this paper
• Protein kinase A inhibition modulates the intracellular routing of gene delivery vehicles in HeLa cells, leading to productive transfection.

  2011cited by this paper
• The ESCRT pathway.

  2011cited by this paper
• Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition.

  2011cited by this paper
• Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.

  2011cited by this paper
• Retrograde Transport: Two (or More) Roads Diverged in an Endosomal Tree?

  2011cited by this paper
• Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule In

  2011cited by this paper
• Role of Rab GTPases in membrane traffic and cell physiology.

  2011influential reference
• Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.

  2011cited by this paper
• Clathrin-independent endocytosis: mechanisms and function.

  2011cited by this paper
• Autophagy for tissue homeostasis and neuroprotection.

  2011cited by this paper
• Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms.

  2010cited by this paper
• The retromer complex.

  2010cited by this paper
• Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor

  2010cited by this paper
• Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

  2010cited by this paper
• Lipid Rafts As a Membrane-Organizing Principle

  2010cited by this paper
• Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles.

  2010cited by this paper
• Lipid rafts, caveolae, and their endocytosis.

  2010cited by this paper
• The Biological Effect of an Antisense Oligonucleotide Depends on Its Route of Endocytosis and Trafficking

  2010cited by this paper
• RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform.

  2010cited by this paper
• Transport at the recycling endosome.

  2010cited by this paper
• Multisubunit tethering complexes and their role in membrane fusion.

  2010cited by this paper
• Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis.

  2010cited by this paper
• Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• Inhibition of retrograde transport protects mice from lethal ricin challenge.

  2010cited by this paper
• Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.

  2010cited by this paper
• Lipid-like materials for low-dose, in vivo gene silencing

  2010cited by this paper
• Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands.

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Biological barriers to therapy with antisense and siRNA oligonucleotides.

  2009cited by this paper
• Endocytosis and signalling: intertwining molecular networks

  2009cited by this paper
• Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

  2009cited by this paper
• Small RNAs in transcriptional gene silencing and genome defence

  2009cited by this paper
• A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

  2009cited by this paper

• Antisense oligonucleotide-loaded nanozyme reverses tumor immune suppression through sonogenetic metabolic therapy.

  2025cites this paper
• Multiplexed siRNA Immunoassay Unveils Spatial and Quantitative Dimensions of siRNA Function, Abundance, and Localization In Vitro and In Vivo

  2025cites this paper
• Recent progress in nanoparticle-mediated RNA interference in insects: Unveiling new frontiers in pest control.

  2025cites this paper
• Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape

  2025cites this paper
• Small Interfering RNA (siRNA) Based Therapies for Cancer Treatment: A Special Focus on Cervical Cancer.

  2025cites this paper
• Unlocking the future: Precision oligonucleotide therapy for targeted treatment of neurodegenerative disorders.

  2025cites this paper
• Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma

  2024cites this paper
• A Review of the Toxicity and Side Effects of Nucleic Acid-based Bio/Nanomaterials

  2024cites this paper
• Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment

  2024cites this paper
• Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications

  2024cites this paper
• Potential of Chitosan for Targeted Mitochondrial Delivery of Therapeutic Agents

  2024cites this paper
• Persistent Targeting DNA Nanocarrier Made of 3D Structural Unit Assembled from Only One Basic Multi‐Palindromic Oligonucleotide for Precise Gene Cancer Therapy

  2024cites this paper
• Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases.

  2023cites this paper
• Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides

  2023cites this paper
• The Dawning of a New Enterprise: RNA Therapeutics for the Skin

  2023cites this paper
• Factors Influencing ADME properties of therapeutic antisense oligonucleotides: physicochemical characteristics and beyond.

  2023cites this paper
• GOLGA8 increases bulk antisense oligonucleotide uptake and activity in mammalian cells.

  2023cites this paper
• Chemistry, structure and function of approved oligonucleotide therapeutics

  2023cites this paper
• A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future

  2023cites this paper
• Incorporation of a TGF-β2-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity in mice

  2023cites this paper
• Cellular Penetration and Intracellular Dynamics of Perfluorocarbon-Conjugated DNA/RNA as a Potential Means of Conditional Nucleic Acid Delivery.

  2023cites this paper
• Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

  2023cites this paper
• Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis

  2023cites this paper
• Oligonucleotide-based therapies for cystic fibrosis.

  2022cites this paper
• Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

  2022cites this paper
• Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias

  2022cites this paper
• The uptake of metal–organic frameworks: a journey into the cell

  2022cites this paper
• An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions

  2022cites this paper
• Cellular uptake, tissue penetration, biodistribution, and biosafety of threose nucleic acids: Assessing in vitro and in vivo delivery

  2022cites this paper
• Nanohydrogels: Advanced Polymeric Nanomaterials in the Era of Nanotechnology for Robust Functionalization and Cumulative Applications

  2022cites this paper
• 2′-O-(N-(Aminoethyl)carbamoyl)methyl Modification Allows for Lower Phosphorothioate Content in Splice-Switching Oligonucleotides with Retained Activity

  2022cites this paper
• A Lysosome‐Activated Tetrahedral Nanobox for Encapsulated siRNA Delivery

  2022cites this paper
• Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery

  2021cites this paper
• Hsc70 Facilitates Mannose-6-Phosphate Receptor-Mediated Intracellular Trafficking and Enhances Endosomal Release of Phosphorothioate-Modified Antisense Oligonucleotides

  2021cites this paper
• Pronounced therapeutic potential of oligonucleotides fixed on inorganic nanoparticles against highly pathogenic H5N1 influenza A virus in vivo.

  2021cites this paper
• Recent Advances in Oligonucleotide Therapeutics in Oncology

  2021cites this paper
• Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates.

  2021cites this paper
• Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats

  2021cites this paper
• Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs

  2021cites this paper
• Biomedical Applications of Antiviral Nanohybrid Materials Relating to the COVID-19 Pandemic and Other Viral Crises

  2021cites this paper
• Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles

  2021cites this paper
• Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles

  2021influential citation
• Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.

  2021cites this paper
• ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery

  2021cites this paper
• Cationic lipid-based formulations for encapsulation and delivery of anti-EFG1 2'OMethylRNA oligomer.

  2021cites this paper
• Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

  2020cites this paper
• Gapmers: Methods and Protocols

  2020cites this paper
• Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases

  2020cites this paper
• Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy

  2020influential citation
• Suppression of cancer stem cells

  2020cites this paper
• The Interaction of Phosphorothioate Containing RNA Targeted Drugs with Proteins is a Critical Determinant of The Therapeutic Effects of These Agents.

  2020cites this paper
• Detection of Locked Nucleic Acid Gapmers from Mouse Muscle Samples Using ELISA.

  2020cites this paper
• Precision guided missile-like DNA nanostructure containing warhead and guidance control for aptamer-based targeted drug delivery into cancer cells in vitro and in vivo.

  2020cites this paper
• Degradation of Toxic RNA in Myotonic Dystrophy Using Gapmer Antisense Oligonucleotides.

  2020cites this paper
• Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD

  2020cites this paper
• LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

  2019cites this paper
• Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.

  2019cites this paper
• Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes

  2019cites this paper
• Light-Triggered Cellular Delivery of Oligonucleotides

  2019cites this paper
• Therapeutic Antisense Oligonucleotides Are Coming of Age.

  2019cites this paper
• Therapeutic Oligonucleotides Against Cancer: Recent Approaches and New Perspectives

  2019cites this paper
• Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy.

  2019cites this paper
• Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

  2019cites this paper
• Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles

  2019cites this paper
• Double-Stranded DNA Fragments Bearing Unrepairable Lesions and Their Internalization into Mouse Krebs-2 Carcinoma Cells

  2019cites this paper
• Observing an antisense drug complex in intact human cells by in-cell NMR

  2019cites this paper
• Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases

  2019cites this paper
• RNA therapeutics: Identification of novel targets leading to drug discovery

  2019cites this paper
• Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery

  2019cites this paper
• Plasma and Liver Protein Binding of N-Acetylgalactosamine–Conjugated Small Interfering RNA

  2019cites this paper
• COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways

  2018cites this paper
• Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop

  2018cites this paper
• Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides

  2018cites this paper
• MicroRNA-Based Drugs for Brain Tumors.

  2018cites this paper
• Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosis

  2018cites this paper
• RNA-Targeted Therapeutics.

  2018cites this paper
• An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides

  2018cites this paper
• Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t

  2018cites this paper
• Antisense oligonucleotides: the next frontier for treatment of neurological disorders

  2018cites this paper
• A novel cell transfection platform based on laser optoporation mediated by Au nanostar layers

  2018cites this paper
• Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis

  2018cites this paper
• Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents.

  2018cites this paper
• Membrane Destabilization Induced by Lipid Species Increases Activity of Phosphorothioate-Antisense Oligonucleotides

  2018cites this paper
• Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy

  2018cites this paper
• Microwave-assisted delivery of an anticancer drug to cancer cells

  2018cites this paper
• State-of-art based approaches for anticancer drug-targeting to nucleus

  2018cites this paper
• Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection

  2018cites this paper
• Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro

  2017cites this paper
• Inside Job: Methods for Delivering Proteins to the Interior of Mammalian Cells.

  2017cites this paper
• Cellular uptake and trafficking of antisense oligonucleotides

  2017cites this paper
• Anti-HIV Activities of Intramolecular G4 and Non-G4 Oligonucleotides

  2017cites this paper
• Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy

  2017cites this paper
• Increasing the affinity of cationized polyacrylamide-paclitaxel nanoparticles towards colon cancer cells by a surface recognition peptide.

  2017cites this paper
• 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.

  2017cites this paper
• Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs

  2017cites this paper
• Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

  2017cites this paper
• Specific Increase of Protein Levels by Enhancing Translation Using Antisense Oligonucleotides Targeting Upstream Open Frames.

  2017cites this paper
• Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides

  2017cites this paper
• Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential.

  2017cites this paper
• Strategies in the design of gold nanoparticles for intracellular targeting: opportunities and challenges.

  2017cites this paper